ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 54909 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 54909; 2) Community: the network communities that were significantly associated with the response to NSC 54909; 3) Molecule: the relationships between components within communities and NSC 54909; 4) MDR: the compounds that were significantly associated with the NSC 54909.

NSC Compound Enrichment Correlation
NSC 662120 4H-Cyclopenta[c]thiophene-4-one, 6-amino- 1,3-dichloro-5,6-dihydro-, hydrochloride 0.0385613993886001 0.66971813
NSC 66301 Null 0.0385613993886001 0.32655807
NSC 665514 Null 0.0385613993886001 0.54338427
NSC 673787 Null 0.0385613993886001 0.041789758
NSC 681632 Camptothecin Derivative 0.0385613993886001 0.15244145
NSC 682815 12H-7,11-Nitrilo-6H,20H-dibenzo[b,m][1,15,5,8,11] dioxatriazacyclodocosine, 21,22,23,24-tetrahydro- (9CI) 0.0385613993886001 0.50815157
NSC 685827 Null 0.0385613993886001 0.24109183
NSC 687578 Null 0.0385613993886001 0.28632628
NSC 693883 Acetaldehyde, 1-chloro-, O-[[(4-fluoro-3-nitrophenyl) amino]carbonyl]oxime 0.0385613993886001 0.27922279
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0385613993886001 0.4218344
Total:162  Current:126    [First] [Prev] [Next] [Last]